基于多参数MRI的VI-RADS:它可以预测1至5年的膀癌复发吗?
Xiaopan Xu1, Yiping Huang2, Yang Liu1
1School of Biomedical Engineering, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi, 710032, People's Republic of China.
European radiology
|November 5, 2023
概括
膀成像报告和数据系统 (VI-RADS) 评分显示了预测膀癌复发的潜力,特别是在第一年内. 然而,随着更长的随访期,它的预测准确性会下降.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 医疗成像医学成像
背景情况:
- 膀癌 (BCa) 复发是一个重大的临床挑战.
- 准确的手术前预后对于指导治疗和监测策略至关重要.
- 多参数MRI (mp-MRI) 提供了膀的详细解剖和功能信息.
研究的目的:
- 评估由mp-MRI获得的膀成像报告和数据系统 (VI-RADS) 评分在预测膀癌复发中的有效性.
- 评估VI-RADS分数在不同后续间隔 (1-5年) 的预后价值.
主要方法:
- 对284名病理确认的膀瘤患者的回顾性分析.
- 两个放射科医生使用VI-RADS系统对mp-MRI扫描进行独立评分.
- 包括皮尔森相关性,t测试和ROC分析在内的统计分析用于复发预测.
主要成果:
- VI-RADS评分表明,在诊断后1-4年内,复发和非复发病例之间存在显著差异 (p <0.05).
- 与得分为3-5 (p <0.05) 的患者相比,VI-RADS得分为1或2的患者的无复发生存率明显更好 (p <0.05).
- 预测复发的ROC曲线下的面积从1年后的0.744下降到5年后的0.536.
结论:
- 在mp-MRI上的VI-RADS评分显示了膀癌复发的术前预后的前景.
- 随着随访时间的延长,VI-RADS的预测性能下降.
- 患有VI-RADS评分≥3的患者可能受益于加强术后监测,因为在1-2年内复发的风险更高.
相关概念视频
Imaging Studies IV: Magnetic Resonance Imaging
11
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
11
Imaging Studies VI: Voiding Cystourethrography and Cystography
10
Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
10


